Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Rodgers Brothers Inc.

Rodgers Brothers Inc. cut its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 43.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 24,175 shares of the company’s stock after selling 18,565 shares during the period. Rodgers Brothers Inc.’s holdings in Azenta were worth $1,209,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in AZTA. Picton Mahoney Asset Management boosted its holdings in Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company’s stock worth $35,000 after buying an additional 532 shares in the last quarter. KBC Group NV boosted its stake in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock worth $107,000 after acquiring an additional 698 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Azenta in the 4th quarter worth approximately $200,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Azenta by 14.9% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company’s stock valued at $225,000 after purchasing an additional 576 shares in the last quarter. Finally, Catalyst Funds Management Pty Ltd raised its holdings in Azenta by 123.0% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 4,684 shares of the company’s stock worth $234,000 after purchasing an additional 2,584 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Trading Down 2.6 %

Azenta stock opened at $34.61 on Monday. The stock has a 50-day moving average price of $45.11 and a 200 day moving average price of $46.27. Azenta, Inc. has a 52 week low of $33.37 and a 52 week high of $63.58. The stock has a market cap of $1.58 billion, a PE ratio of -11.61 and a beta of 1.52.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.

Wall Street Analyst Weigh In

AZTA has been the subject of a number of research analyst reports. Needham & Company LLC raised their price target on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research report on Thursday, February 6th. Stephens restated an “overweight” rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI upped their price target on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. Finally, TD Cowen raised shares of Azenta to a “hold” rating in a research note on Thursday, February 27th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Azenta has an average rating of “Hold” and a consensus target price of $58.75.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.